Table 2.

Maternal and neonatal outcomes for 312,081 pregnant women in Alberta from January 1, 2005, to December 31, 2014.*

CharacteristicsNo IARASpA**p
Preterm delivery21,997 (7.1)85 (13.5)181 (7.4)< 0.01
Cesarean delivery87,771 (28.4)214 (33.9)715 (29.1)< 0.01
Elective cesarean delivery37,053 (12.0)95 (15.1)338 (13.7)< 0.01
Emergent cesarean delivery50,718 (16.4)119 (18.9)377 (15.3)0.09
Induction82,415 (26.7)182 (28.8)722 (29.3)< 0.01
Mortality within 40 days of birth17 (0.0)0 (0.0)1 (0.0)0.07
Hypertensive disorders in pregnancy***19,831 (6.4)66 (10.5)179 (7.3)< 0.01
Gestational diabetes18,595 (6.0)32 (5.1)162 (6.6)0.3
Birth weight, g, mean (SD)3349 (562)3224 (597)3364 (548)< 0.01
Small for gestational age34,757 (11.3)98 (15.6)260 (10.6)< 0.01
Large for gestational age27,706 (9.0)62 (9.8)238 (9.7)0.36
Neonatal death within 30 days of birth973 (0.3)3 (0.5)11 (0.4)0.39
Congenital anomaly5751 (1.9)18 (2.9)52 (2.1)0.12
Mean (SD) days in NICU0.8 (5.0)1.2 (5.7)0.8 (4.5)0.14
  • Data are n (%) unless otherwise indicated.

  • * Sensitivity analyses evaluating maternal and neonatal outcomes in primiparous women revealed similar results.

  • ** Includes SpA, ankylosing spondylitis, psoriasis, and psoriatic arthritis.

  • *** Includes gestational hypertension, preeclampsia, and eclampsia. IA: inflammatory arthritis; RA: rheumatoid arthritis; SpA: spondyloarthritis; NICU: neonatal intensive care unit.